Counting tumor cells in blood predicts treatment benefit in prostate cancer

Links shared publicly online about this topic.

2,793
total visits

Counting tumor cells in blood predicts treatment benefit in prostate cancer

Counting the number of tumor cells circulating in the bloodstream of patients with castration-resistant prostate cancer can accurately predict how well they are responding to treatment, new results show. At the ESMO Conference Lugano organized by the European Society for Medical Oncology, researchers showed that changes in the number of circulating tumor cells predicted the outcome after chemotherapy in this hard to treat cancer.

View full resource at eurekalert.org

Tags: Cancer, Chemotherapy, Prostate Cancer, Prostate, Men's Health, Oncology